102 related articles for article (PubMed ID: 18819001)
1. BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.
Ottini L; Rizzolo P; Zanna I; Falchetti M; Masala G; Ceccarelli K; Vezzosi V; Gulino A; Giannini G; Bianchi S; Sera F; Palli D
Breast Cancer Res Treat; 2009 Aug; 116(3):577-86. PubMed ID: 18819001
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy.
Miolo G; Puppa LD; Santarosa M; De Giacomi C; Veronesi A; Bidoli E; Tibiletti MG; Viel A; Dolcetti R
BMC Cancer; 2006 Jun; 6():156. PubMed ID: 16764716
[TBL] [Abstract][Full Text] [Related]
3. PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer.
Deb S; Do H; Byrne D; Jene N; ; Dobrovic A; Fox SB
Breast Cancer Res; 2013; 15(4):R69. PubMed ID: 23971979
[TBL] [Abstract][Full Text] [Related]
4. Pleomorphic/solid lobular carcinoma of male breast with PALB2 germline mutation: case report and literature review.
Rogges E; Corati T; Amato M; Campagna D; Farro J; De Toffol S; Fortunato L; Costarelli L
Pathologica; 2024 Feb; 116(1):62-68. PubMed ID: 38482676
[TBL] [Abstract][Full Text] [Related]
5. The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort.
Hu C; Polley EC; Yadav S; Lilyquist J; Shimelis H; Na J; Hart SN; Goldgar DE; Shah S; Pesaran T; Dolinsky JS; LaDuca H; Couch FJ
J Natl Cancer Inst; 2020 Dec; 112(12):1231-1241. PubMed ID: 32091585
[TBL] [Abstract][Full Text] [Related]
6. Mutations in
Fasching PA; Yadav S; Hu C; Wunderle M; Häberle L; Hart SN; Rübner M; Polley EC; Lee KY; Gnanaolivu RD; Hadji P; Hübner H; Tesch H; Ettl J; Overkamp F; Lux MP; Ekici AB; Volz B; Uhrig S; Lüftner D; Wallwiener M; Müller V; Belleville E; Untch M; Kolberg HC; Beckmann MW; Reis A; Hartmann A; Janni W; Wimberger P; Taran FA; Fehm TN; Wallwiener D; Brucker SY; Schneeweiss A; Hartkopf AD; Couch FJ
J Clin Oncol; 2021 May; 39(15):1619-1630. PubMed ID: 33780288
[TBL] [Abstract][Full Text] [Related]
7. Male breast cancer risk associated with pathogenic variants in genes other than BRCA1/2: an Italian case-control study.
Bucalo A; Conti G; Valentini V; Capalbo C; Bruselles A; Tartaglia M; Bonanni B; Calistri D; Coppa A; Cortesi L; Giannini G; Gismondi V; Manoukian S; Manzella L; Montagna M; Peterlongo P; Radice P; Russo A; Tibiletti MG; Turchetti D; Viel A; Zanna I; Palli D; Silvestri V; Ottini L
Eur J Cancer; 2023 Jul; 188():183-191. PubMed ID: 37262986
[TBL] [Abstract][Full Text] [Related]
8. Familial relative risks for breast cancer by pathological subtype: a population-based cohort study.
Mavaddat N; Pharoah PD; Blows F; Driver KE; Provenzano E; Thompson D; Macinnis RJ; Shah M; ; Easton DF; Antoniou AC
Breast Cancer Res; 2010; 12(1):R10. PubMed ID: 20146796
[TBL] [Abstract][Full Text] [Related]
9. The pathology of hereditary breast cancer.
Honrado E; Benítez J; Palacios J
Hered Cancer Clin Pract; 2004 Jul; 2(3):131-8. PubMed ID: 20233467
[TBL] [Abstract][Full Text] [Related]
10. Identification of a new BRCA2 large genomic deletion associated with high risk male breast cancer.
Timoteo AR; Albuquerque BM; Moura PC; Ramos CC; Agnez-Lima LF; Walsh T; King MC; Lajus TB
Hered Cancer Clin Pract; 2015; 13(1):2. PubMed ID: 25632310
[TBL] [Abstract][Full Text] [Related]
11.
Huszno J; Fiszer-Kierzkowska A; Pigłowski W; Mazur M
Prz Menopauzalny; 2019 Dec; 18(4):227-229. PubMed ID: 32132887
[TBL] [Abstract][Full Text] [Related]
12. Malignant Abnormalities in Male BRCA Mutation Carriers: Results From a Prospectively Screened Cohort.
Mano R; Tamir S; Kedar I; Benjaminov O; Baniel J; Tabachnik T; Margel D
JAMA Oncol; 2018 Jun; 4(6):872-874. PubMed ID: 29710070
[TBL] [Abstract][Full Text] [Related]
13. Genetic Landscape of Male Breast Cancer.
Campos FAB; Rouleau E; Torrezan GT; Carraro DM; Casali da Rocha JC; Mantovani HK; da Silva LR; Osório CABT; Moraes Sanches S; Caputo SM; Santana Dos Santos E
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298749
[TBL] [Abstract][Full Text] [Related]
14. Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients.
Al Saati A; Vande Perre P; Plenecassagnes J; Gilhodes J; Monselet N; Cabarrou B; Lignon N; Filleron T; Telly D; Perello-Lestrade E; Feillel V; Staub A; Martinez M; Chipoulet E; Collet G; Thomas F; Gladieff L; Toulas C
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762649
[TBL] [Abstract][Full Text] [Related]
15. Male Breast Cancer (MBC) - A Review.
AlFehaid M
Pol Przegl Chir; 2023 Dec; 95(6):24-30. PubMed ID: 38058163
[TBL] [Abstract][Full Text] [Related]
16. Pioneering Informed Consent for Return of Research Results to Breast Cancer Patients Facing Barriers to Implementation of Genomic Medicine: The Kenyan BRCA1/2 Testing Experience Using Whole Exome Sequencing.
Torrorey-Sawe R; van der Merwe N; Mining SK; Kotze MJ
Front Genet; 2020; 11():170. PubMed ID: 32231682
[TBL] [Abstract][Full Text] [Related]
17. Male breast cancer: a review.
Fentiman I
Ecancermedicalscience; 2009; 3():140. PubMed ID: 22276005
[TBL] [Abstract][Full Text] [Related]
18. Male breast cancer: an update in diagnosis, treatment and molecular profiling.
Onami S; Ozaki M; Mortimer JE; Pal SK
Maturitas; 2010 Apr; 65(4):308-14. PubMed ID: 20138719
[TBL] [Abstract][Full Text] [Related]
19. Male Breast Cancer: From Molecular Genetics to Clinical Management.
Pensabene M; Von Arx C; De Laurentiis M
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454911
[TBL] [Abstract][Full Text] [Related]
20. Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study.
Marcheselli R; Marcheselli L; Cortesi L; Bari A; Cirilli C; Pozzi S; Ferri P; Napolitano M; Federico M; Sacchi S
J Breast Cancer; 2015 Dec; 18(4):378-85. PubMed ID: 26770245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
